Strategies Targeting the Hallmarks of #Cancer - This figure illustrates some of the many approaches employed in developing therapeutics targeted to the known and emerging hallmarks of cancer.    EGFR indicates epidermal growth factor receptor; CTLA4, cytotoxic T lymphocyte-associated antigen 4; mAb, monoclonal antibody; HGF, hepatocyte growth factor; #VEGF, vascular #endothelial growth factor; PARP, poly-(ADP ribose) polymerase.